fashion -WSS

fashion

author：explore 2025-09-07 14:11:13 - browse：66117

Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store. — The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

“This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： STAT Summit: How researchers deal with rejection

WSS

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

STAT Summit: The economic case for universal basic health care

Female surgeons have lower rates of long

How clinical AI models' predictive power can degrade over time

STAT Summit: Ending the crisis of Black deaths in the U.S.

Peter Marks talks Operation Warp Speed for Rare Diseases

focus

fashion

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Eight reasons why you should get an updated Covid vaccine

The cancer drug shortage isn’t new — and neither are the solutions

How should state employee insurance handle Wegovy?

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Readout Newsletter: Biotech news today

Medical leaders decry Supreme Court decision on affirmative action

CZI to create biohub to build anti

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: Merger Mondays, Ozempic panic

explore

Roche drug slashes death risk in early

Health tech investors get more selective as pandemic boom fades

Akero's treatment for NASH falls short in cirrhosis study

STAT Summit: The economic case for universal basic health care

Life sciences deals on track to hit lowest point since 2017

FDA clears Verve to begin U.S. study of gene

Wikipedia

hotspot

explore

focus